Chemoinformaics analysis of mallotophilippen A
Molecular Weight | 498.572 | nRot | 7 |
Heavy Atom Molecular Weight | 464.3 | nRig | 19 |
Exact Molecular Weight | 498.225 | nRing | 3 |
Solubility: LogS | -3.751 | nHRing | 1 |
Solubility: LogP | 6.25 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
nHA | 8 | APOL | 75.847 |
nHD | 5 | BPOL | 37.581 |
QED | 0.321 |
Synth | 3.96 |
Natural Product Likeliness | 2.136 |
NR-PPAR-gamma | 0.412 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.655 |
Pgp-sub | 0.004 |
HIA | 0.458 |
CACO-2 | -5.277 |
MDCK | 0.0000189 |
BBB | 0.002 |
PPB | 1.02305 |
VDSS | 0.261 |
FU | 0.00767967 |
CYP1A2-inh | 0.177 |
CYP1A2-sub | 0.883 |
CYP2c19-inh | 0.115 |
CYP2c19-sub | 0.177 |
CYP2c9-inh | 0.698 |
CYP2c9-sub | 0.753 |
CYP2d6-inh | 0.277 |
CYP2d6-sub | 0.167 |
CYP3a4-inh | 0.193 |
CYP3a4-sub | 0.395 |
CL | 1.651 |
T12 | 0.083 |
hERG | 0.005 |
Ames | 0.035 |
ROA | 0.048 |
SkinSen | 0.954 |
Carcinogencity | 0.119 |
EI | 0.817 |
Respiratory | 0.175 |
NR-Aromatase | 0.923 |
Antiviral | Yes |
Prediction | 0.878136 |